<img alt="" src="https://secure.agile-company-365.com/781893.png" style="display:none;">
the microsampling blog

overcoming hematocrit accuracy issues: VAMS vs. DBS

strategies for overcoming hematocrit accuracy issues in dried blood sampling
4:30

a DBS filter paper card next to the purple Mitra Cartridge blood sampler

 
Overcoming the hematocrit (HCT) effect has long challenged the adoption of dried blood spot (DBS) sampling. Hematocrit bias, from varying red blood cell proportions in whole blood, causes major inaccuracy in quantitative DBS analyses.
 
This problem has spurred the search for precise microsampling, vital for tasks needing strict quantitation, like therapeutic drug monitoring and biomarker assessment.
 
Can DBS or microfluidic blood sampling overcome hematocrit bias and deliver results as reliable as those from conventional venous sampling?

Volumetric Microsampling and Microfluidic-Based Solutions to Hematocrit Bias

Volumetric absorptive microsampling (VAMS) improves on traditional DBS by collecting a fixed, accurate blood volume, regardless of hematocrit or viscosity.
 
This quantitative dried blood method reduces inaccuracies and allows robust, reproducible analyses. Volumetric microsampling can also lower costs for handling and shipping because samples remain viable at room temperature.
 
Mitra® devices with patented VAMS® technology make it possible to draw fixed volume blood samples of 10, 20, and 30 µL (microliters) from a single finger prick.
 
This method is less invasive than venipuncture methods that draw blood volumes approximately one thousand times greater.

a women places the Mitra microsampler near her finger to collect a drop of blood.


Hematocrit Accuracy Issues in Dried Blood Spot (DBS) Microsampling

blood supply does not support conventional venipuncture. With DBS, a drop of blood drawn from the infant’s finger or heel is placed on a specially treated filter paper (Guthrie or Whatman) or card for analysis.
 
Similarly, a Mitra® device with its absorptive VAMS® tip enables a quick blood draw with a finger-stick using a small lancet. The resulting microsamples will be processed as DBS samples, requiring no refrigeration for storage or transport.
 
Lab analyses show a key problem with standard DBS: hematocrit-dependent inaccuracy. Quantitative analyte measurements can be misleading due to the uneven distribution of red blood cells and plasma in the dried matrix. This unevenness affects both sample consistency and analyte recovery.
 
In traditional DBS, blood is placed on a filter card to spread. Viscosity, influenced by hematocrit, affects how the blood spreads. Higher hematocrit increases viscosity and limits spreading. Lower hematocrit reduces viscosity, causing it to spread more.
 
This makes analyte levels from unit areas inconsistent between samples and complicates accuracy and reproducibility.

 

Hematocrit levels in a sample may vary based on hydration. More hydrated, lower-viscosity samples spread farther on dried blood paper and can yield lower hematocrit when the area is punched from the DBS card. Smaller, more viscous samples show higher hematocrit. These variations can cause inconsistent analytical data.
 
Several strategies have been developed to mitigate hematocrit-associated inaccuracy in DBS analyses. Modifications such as perforated or precut card designs, as well as patterned DBS (pDBS) with wax barriers, restrict blood spreading and help define a fixed sampling area.
 
These microfluidic-based modifications improve volume accuracy and reduce hematocrit bias, enabling more reliable quantitative dried blood analyses.
 
But the best innovation was yet to come.

 

Strategic Advantages of VAMS over DBS

visual depictions of the various issues associated with DBs filter paper, next to a VAMS blood collection tip

Volumetric absorptive microsampling (VAMS) is a viable alternative to DBS for overcoming hematocrit bias. Devices like Mitra with VAMS use microfluidic tips to collect a precise, fixed blood volume, regardless of viscosity or hematocrit.
 
Each sample is consistent and reproducible, removing a major source of DBS error. Studies confirm VAMS provides greater accuracy and precision in quantifying analytes, especially when hematocrit varies.
 
Also, dried blood microsamples do not require refrigeration or special handling. The Mitra device is designed for easy sampling by anyone, anywhere. For many research studies, participants have successfully self-collected their samples at home or in other remote locations.
 
In the laboratory, sophisticated equipment and techniques can analyze microsamples as accurately as liquid blood samples or larger specimen samples.
 
If you haven't yet explored the advantages of volumetric microsampling technology, discover the possibilities
 

In some territories our devices are supplied for therapeutic or IVD use Outside of those territories our devices are supplied for research use only 

Comments (2)

Receive Blog Notifications